[go: up one dir, main page]

PE20061081A1 - Derivados de bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion y composiciones que las contienen - Google Patents

Derivados de bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion y composiciones que las contienen

Info

Publication number
PE20061081A1
PE20061081A1 PE2005001356A PE2005001356A PE20061081A1 PE 20061081 A1 PE20061081 A1 PE 20061081A1 PE 2005001356 A PE2005001356 A PE 2005001356A PE 2005001356 A PE2005001356 A PE 2005001356A PE 20061081 A1 PE20061081 A1 PE 20061081A1
Authority
PE
Peru
Prior art keywords
alkyl
preparation procedure
caprolactama
bengamides
derivatives
Prior art date
Application number
PE2005001356A
Other languages
English (en)
Inventor
Zhang Jidong
Neerja Bhatnagar
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PE20061081A1 publication Critical patent/PE20061081A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA (I) DONDE R1 ES H, ALQUILO(C1-C24), CICLOALQUILO(C3-C9), ALQUIL(C1-C8)-ARIL-O-ALQUILO(C1-C24), ENTRE OTROS; R2 ES H, OR7, OCO(R7) DONDE R7 ES ALQUILO(C1-C24), CICLOALQUILO(C3-C9), ALQUILENO(C3-C24), ENTRE OTROS; R4, R5 Y R6 SON CADA UNO H, ACILO(C1-C6), ALQUILO(C1-C6), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: N-[(S)-1-(4-BENCIL)-2-OXO-PERHIDRO-AZEPIN-3-IL]-(E)-(2R,3R,4S,5R)-3,4,5-TRIHIDROXI-2-METOXI-8-METIL-DEC-6-ENAMIDA, N-[(S)-1-(4-TERC-BUTIL-BENCIL)-2-OXO-PERHIDRO-AZEPIN-3-IL]-(E)-(2R,3R,4S,5R)-3,4,5-TRIHIDROXI-2-METOXI-8-METIL-DEC-6-ENAMIDA, N-[(S)-2-OXO-1-(3-TRIFLUOROMETIL-BENCIL)-PERHIDRO-AZEPIN-3-IL]-(E)-(2R,3R,4S,5R)-3,4,5-TRIHIDROXI-2-METOXI-8-METIL-DEC-6-ENAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON UTILES COMO AGENTES ANTICANCEROSOS
PE2005001356A 2004-11-29 2005-11-18 Derivados de bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion y composiciones que las contienen PE20061081A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0412646A FR2878525B1 (fr) 2004-11-29 2004-11-29 Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation

Publications (1)

Publication Number Publication Date
PE20061081A1 true PE20061081A1 (es) 2006-12-08

Family

ID=34954085

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005001356A PE20061081A1 (es) 2004-11-29 2005-11-18 Derivados de bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion y composiciones que las contienen

Country Status (17)

Country Link
US (2) US20070249584A1 (es)
EP (1) EP1819680B1 (es)
JP (1) JP2008521779A (es)
KR (1) KR20070089723A (es)
CN (1) CN101065361A (es)
AR (1) AR052035A1 (es)
AT (1) ATE545632T1 (es)
AU (1) AU2005308709A1 (es)
BR (1) BRPI0516663A (es)
CA (1) CA2585990A1 (es)
FR (1) FR2878525B1 (es)
IL (1) IL183189A0 (es)
MX (1) MX2007006042A (es)
PE (1) PE20061081A1 (es)
RU (1) RU2007123394A (es)
TW (1) TW200630342A (es)
WO (1) WO2006056695A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153846B2 (en) * 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
FR2878525B1 (fr) * 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2878528B1 (fr) * 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2901555A1 (fr) * 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) * 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) * 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
GB2451451A (en) * 2007-07-30 2009-02-04 Inion Ltd Osteogenic compounds
CN101456824B (zh) * 2007-12-11 2013-04-17 中国科学院上海药物研究所 α-氨基-N-取代酰胺化合物、包含该化合物的药物组合物及其用途
CN102911118B (zh) * 2012-11-09 2014-04-09 天津商业大学 一类苯并氮杂卓类衍生物及其制备方法和用途
CN109320456A (zh) * 2018-11-16 2019-02-12 天津商业大学 新晶型的抗肿瘤化合物及其制备方法和含其的组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692522A (en) 1985-04-01 1987-09-08 Merck & Co., Inc. Benzofused lactams useful as cholecystokinin antagonists
US4831135A (en) 1986-06-18 1989-05-16 The Regents Of The University Of California Bengamide anthelmintics
US5283241A (en) 1992-08-28 1994-02-01 Merck & Co., Inc. Benzo-fused lactams promote release of growth hormone
GB9411841D0 (en) 1994-06-14 1994-08-03 Pharma Mar Sa New antitumoral compounds from jaspis sponge
JP2002241368A (ja) 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
CO5140099A1 (es) * 1998-11-17 2002-03-22 Novartis Ag Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
US6239127B1 (en) 1999-11-17 2001-05-29 Novartis Ag Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation
DE60132324T2 (de) 2000-05-11 2008-12-24 Novartis Ag Substituierte caprolactam carbonate und ether sowie deren verwendung als anti-tumor wirkstoffe
AU2002217020A1 (en) 2000-11-14 2002-05-27 Novartis Ag Method for screening anti-proliferative compounds and inhibiting tumor growth
US6545148B2 (en) 2001-03-12 2003-04-08 Novartis Ag Process for preparing certain substituted caprolactams
JP2004262793A (ja) * 2003-02-28 2004-09-24 Noyaku Bio Technology Kaihatsu Gijutsu Kenkyu Kumiai 化合物ｎ−９０１１、その製造法及び用途
MXPA06000975A (es) * 2003-07-25 2006-04-11 Novartis Ag Lactams sustituidos y su uso como agentes anti-cancer.
DE10349669B3 (de) * 2003-10-24 2005-05-25 Aventis Pharma Deutschland Gmbh Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US7153846B2 (en) * 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
FR2878528B1 (fr) 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2878525B1 (fr) 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2901556A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
US20090007597A1 (en) * 2007-07-02 2009-01-08 Hanevold Gail F Body attached band with removal visual image pockets

Also Published As

Publication number Publication date
WO2006056695A1 (fr) 2006-06-01
AU2005308709A1 (en) 2006-06-01
AR052035A1 (es) 2007-02-28
CN101065361A (zh) 2007-10-31
BRPI0516663A (pt) 2008-09-16
CA2585990A1 (fr) 2006-06-01
WO2006056695A8 (fr) 2007-04-05
JP2008521779A (ja) 2008-06-26
FR2878525A1 (fr) 2006-06-02
US20070249584A1 (en) 2007-10-25
MX2007006042A (es) 2007-07-10
EP1819680B1 (fr) 2012-02-15
ATE545632T1 (de) 2012-03-15
TW200630342A (en) 2006-09-01
EP1819680A1 (fr) 2007-08-22
RU2007123394A (ru) 2009-01-10
FR2878525B1 (fr) 2007-02-23
KR20070089723A (ko) 2007-08-31
US7585855B2 (en) 2009-09-08
IL183189A0 (en) 2007-08-19
US20080318928A1 (en) 2008-12-25

Similar Documents

Publication Publication Date Title
PE20070138A1 (es) Compuestos heterociclicos como inhibidores de aspartil proteasas
PE20070011A1 (es) Formulaciones farmaceuticas de compuestos inhibidores de proteasa del vhc o catepsina
PE20040644A1 (es) Nuevos derivados de quinuclidina-amina
PE20090620A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
PE20050729A1 (es) Aminas ciclicas sustituidas por bezamida o piridin-carboxamida como inhibidores de bace-1
EA200601773A1 (ru) Тетраазабензо[е]азуленовые производные и их аналоги
AR048376A1 (es) C- glicosidos heterociclos fusionados sustituidos
PE20061081A1 (es) Derivados de bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion y composiciones que las contienen
PE20050462A1 (es) COMPUESTOS DE 5,7-DIAMINOPIRAZOLO[4,3-d]PIRIMIDINAS COMO INHIBIDORES DE LA FOSFODIESTERASA TIPO 5 (PDE-5)
PE20080889A1 (es) Aminometil-4-imidazoles
AR047076A1 (es) Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas
EA200301121A1 (ru) Тартраты 5,8,14-триазатетрацикло[10.3.1.02,11.04,9]гексадека-2(11),3,5,7,9-пентаена
PE20080704A1 (es) Inhibidores ns5b del virus hepatitis c de indolobenzazepina fusionados a ciclopropilo
PE20070115A1 (es) Derivados de [1,3,5]-triazina como inhibidores de aspartil proteasas
PE20090326A1 (es) Compuestos heterociclos como inhibidores de erk
PE20090712A1 (es) Moduladores de la gamma secretasa
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
MY142423A (en) Substituted aminoacetyl pyrrolidine compounds which are dipeptidyl peptidase iv inhibitors, and pharmaceutical compositions containing them
PE20070531A1 (es) Compuestos heterociclicos como inhibidores de aspartil proteasas
MA30056B1 (fr) Formulation de precurseur de medicament contre le hcv
PE20110833A1 (es) Nuevas octahidrociclopenta[c]pirrol-4-aminas sustituidas como bloqueantes de los canales de calcio
CR8249A (es) Forma cristalina gamma del clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que lo contienen
PE20090070A1 (es) Derivados de furano como agentes antiinfecciosos
AR042346A1 (es) Sales de aluminio poco irritantes y de alta eficacia y las composiciones antitranspirantes que las contienen

Legal Events

Date Code Title Description
FC Refusal